Penzberg, Germany

Sarah Liedke

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sarah Liedke. Retrieved from https://idiyas.com/inventor/sarah-liedke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Sarah Liedke

Introduction

Sarah Liedke is a prominent inventor based in Penzberg, Germany. She has made significant contributions to the field of medical diagnostics, particularly in the development of antibodies for cardiac health. Her work is recognized for its potential to improve diagnostic accuracy and patient outcomes.

Latest Patents

One of Sarah Liedke's notable patents is related to anti-troponin T antibodies. This invention focuses on improved variant monoclonal antibodies that bind to cardiac troponin T. These antibodies exhibit a better affinity than the previously established monoclonal antibody 12.1A11.11-7. The patent is a significant advancement in cardiac diagnostics, as it enhances the detection of heart-related conditions.

Career Highlights

Sarah Liedke is currently employed at Roche Diagnostics Operations, Inc., a leading company in the field of medical diagnostics. Her role involves research and development, where she applies her expertise to create innovative solutions for healthcare challenges. With her dedication and skill, she has established herself as a valuable asset to her team.

Collaborations

Sarah has collaborated with notable colleagues, including Frank Kroner and Michael Schraeml. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Sarah Liedke is an accomplished inventor whose work in developing anti-troponin T antibodies has the potential to revolutionize cardiac diagnostics. Her contributions to Roche Diagnostics Operations, Inc. and her collaborations with esteemed colleagues highlight her commitment to advancing medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…